Childhood Hodgkin Lymphoma Treatment–for health professionals (PDQ®)

SECTIONS

Changes to This Summary (02/03/2016)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Diagnosis and Staging Information for Childhood Hodgkin Lymphoma

Added Figure 1 about the variation in risk stratification across pediatric Hodgkin study groups and protocols (cited Mauz-Körholz et al. as reference 18).

This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Late Effects from Childhood/Adolescent Hodgkin Lymphoma Therapy

Next section >
About This PDQ Summary